CSF3 and congenital rubella syndrome: -Tociluzimab/Dexamethasone for CRS-Transfusion support-Avoid granulocyte colony stimulating factor in first 14–21 days-Antibiotic prophylaxis and empiric coverage for fevers-Possible alteration of lymphodepleting regimens [50]